.svg){kind=small}
Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
SUNO is stocked at 185 licensed dispensaries across Michigan and Arizona, 146 of them in Michigan, with the deepest coverage in New Buffalo, Monroe, Lansing, Detroit, and Adrian. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
SUNO’s August 2026 category mix is anchored by Tincture & Sublingual at 41.50% share with 425.98% year-over-year growth and 22.70% month-over-month growth, while Concentrates holds 33.57% share with 123.49% year-over-year and 28.72% month-over-month gains. Capsules accounts for 20.40% share with 91.10% year-over-year and 3.46% month-over-month growth, and Topical contributes 4.53% share with 266.24% year-over-year and 33.18% month-over-month expansion. With brand-level sales up 187.17% year-over-year and average price up 9.36%, the pattern implies SUNO is accelerating volume-led gains in value-oriented formats while maintaining pricing power sufficient to lift mix-weighted revenue.
The surge in Tincture & Sublingual and Concentrates, together contributing 75.07% share, paired with a 24th rank in Concentrates in Arizona, suggests SUNO is scaling into efficacy-led use cases while building traction in a higher-price-per-unit segment. The comparatively modest 3.46% month-over-month growth in Capsules against 28.72% in Concentrates and 22.70% in Tincture & Sublingual indicates resource pull toward faster-moving platforms, while Topical’s 33.18% month-over-month rise from a 4.53% base points to a testing ground for incremental trial. Taken together, these shifts imply a positioning pivot toward potency-forward and routine wellness formats that can sustain share growth without over-reliance on discounting.
Competitive Landscape
In Arizona Concentrates for August 2026, SUNO is ranked #24, improving 6 positions from #30 year over year, and edging up 4 spots from #28 since May 2026; the brand also hit its peak rank of #24 in August 2026, which contrasts with Grow Sciences advancing from #6 to #3 on a 32.34% YoY sales lift and Hi-Klas jumping from #23 to #5 alongside a 332.24% YoY sales increase. Compared with the stable leadership of Mohave Cannabis Co. holding #1 both this year and last despite a -2.65% YoY sales change, SUNO’s move from #30 to #24 indicates incremental share capture rather than market reordering, implying a trajectory that relies on steady gains amid faster-moving rivals.
Notable Products
Hybride RSO (1g) posted the month’s sharpest move at +54.7% MoM, climbing to rank 4 while Hybrid Rso Tablets 10-Pack (100mg) advanced +30.7% to rank 1. In contrast, Hybrid Unflavored RSO Tincture (100mg) fell -14.0% and slid to rank 3 as broader Tincture & Sublingual entries ranged from -2.6% at rank 7 to +1.6% at rank 9. With three Capsules in the top six and four Tincture & Sublingual SKUs in the top ten, the mix tilts toward routine dose formats, while a high-velocity concentrate at rank 4 signals a pivot toward potency-driven trial alongside daily-use anchors; this implies SUNO is balancing dependable capsule demand with a targeted push into higher-intensity formats.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
